CCR8 and myeloid sarcoma: CCR8 KO mice showed reduced EAE. CCR8 has been clearly demonstrated to play an essential role in EAE progression (111). CCR8 expression correlated with the demyelinating activity, but was not restricted to the MS pathology (112).